We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$2.64B
AUM Growth
+$69.3M
Cap. Flow
+$163M
Cap. Flow %
6.15%
Top 10 Hldgs %
15.9%
Holding
1,827
New
629
Increased
253
Reduced
185
Closed
664

Top Buys

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$46.9M
2
PBCT
People's United Financial Inc
PBCT
+$42.2M
3
MMM icon
3M
MMM
+$39.9M
4
LOW icon
Lowe's Companies
LOW
+$38.4M
5
EMR icon
Emerson Electric
EMR
+$35.8M

Top Sells

Rank Stock Value
1
EPAM icon
EPAM Systems
EPAM
+$40.2M
2
DHR icon
Danaher
DHR
+$37.9M
3
SO icon
Southern Company
SO
+$37.6M
4
KLAC icon
KLA
KLAC
+$33.8M
5
WFC icon
Wells Fargo
WFC
+$31.8M

Sector Composition

Rank Sector Weight
1 Technology 19.33%
2 Financials 16.14%
3 Industrials 11.04%
4 Consumer Discretionary 7.83%
5 Healthcare 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQRX
1726
DELISTED
EQRx, Inc. Common Stock
EQRX
-76,635
Closed -$523K
ICPT
1727
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-52,210
Closed -$851K
DEN
1728
DELISTED
Denbury Inc.
DEN
-31,329
Closed -$2.4M
NATI
1729
DELISTED
National Instruments Corp
NATI
-5,150
Closed -$225K
VCSA
1730
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
-13,429
Closed -$2.23M
SYNH
1731
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
-2,261
Closed -$232K
RETA
1732
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-45,955
Closed -$1.21M
FOCS
1733
DELISTED
Focus Financial Partners Inc. Class A
FOCS
-5,100
Closed -$305K
IDEX
1734
DELISTED
Ideanomics, Inc. Common Stock
IDEX
-4,789
Closed -$718K
ARNC
1735
DELISTED
Arconic Corporation
ARNC
-48,644
Closed -$1.61M
UBP
1736
DELISTED
Urstadt Biddle Properties Inc.
UBP
-2,100
Closed -$40K
PDCE
1737
DELISTED
PDC Energy, Inc.
PDCE
-16,599
Closed -$810K
VRAY
1738
DELISTED
ViewRay, Inc.
VRAY
-29,400
Closed -$162K
ISEE
1739
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-98,520
Closed -$1.65M
NYMX
1740
DELISTED
Nymox Pharmaceutical Corp
NYMX
-101,332
Closed -$132K
XM
1741
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
-87,424
Closed -$3.1M
CVT
1742
DELISTED
Cvent Holding Corp. Common Stock
CVT
-63,383
Closed -$518K
RUTH
1743
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
-15,811
Closed -$315K
PEAR
1744
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
-36,300
Closed -$225K
GLS
1745
DELISTED
Gelesis Holdings, Inc.
GLS
-14,281
Closed -$142K
BOXD
1746
DELISTED
Boxed, Inc.
BOXD
-61,597
Closed -$844K
MYOV
1747
DELISTED
Myovant Sciences Ltd.
MYOV
-25,847
Closed -$402K
RUBY
1748
DELISTED
Rubius Therapeutics, Inc
RUBY
-30,314
Closed -$293K
CAJ
1749
DELISTED
Canon, Inc.
CAJ
-10,800
Closed -$264K
LHCG
1750
DELISTED
LHC Group LLC
LHCG
-2,674
Closed -$367K

Similar funds

Ergoteles's Q1 2022 Portfolio in Review

As of Q1 2022, Ergoteles held 1,827 positions worth $2.64B, up 2.7% from $2.57B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Ergoteles deployed $163M of net new capital in Q1 2022, opening 629 new positions and adding to 253 existing holdings. Its largest new stake was 3M: 299,716 shares worth $37.3M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Danaher, an estimated $37.9M trimmed.

  • Ergoteles's largest Q1 2022 buy was 3M: 299,716 shares worth $37.3M.
  • Ergoteles added most to Oracle in Q1 2022, an estimated $46.9M increase.
  • Ergoteles's biggest Q1 2022 reduction was Danaher, cutting an estimated $37.9M.
  • Ergoteles fully exited EPAM Systems in Q1 2022, selling an estimated $40.2M.
  • Ergoteles's ten largest holdings make up 16% of its $2.64B portfolio in Q1 2022.
  • Ergoteles opened 629 new positions and closed 664 in Q1 2022.
  • Ergoteles's portfolio value rose 2.7% quarter-over-quarter to $2.64B.

Based on Ergoteles's 13F filing for Q1 2022, filed 13 May 2022.